Índice Bovespa

US Dollar vs BRL

Cadastre-se para alertas em tempo real, use o simulador personalizado e observe os movimentos do mercado.

Cadastre-se

ATHE Alterity Therapeutics Limited

2,05

-0,09 (-4,21%)

19 Abr 2024 - Fechado

Atrasado em 15 minutos

Alterity announces publication of animal study on lead asset

To read the full story on Seeking Alpha, click here.

Alterity Therapeutics (NASDAQ:ATHE)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024

Click aqui para mais gráficos Alterity Therapeutics.

Alterity Therapeutics (NASDAQ:ATHE)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024

Click aqui para mais gráficos Alterity Therapeutics.

Notícias Alterity Therapeutics Limited

Alterity Therapeutics Parkinson’s Disease and Multiple System Atrophy Data Featured at the American Academy of Neurology (AAN) 2024 Annual Meeting
Quarta, 17 de Abril de 2024 (3 dias atrás) • GlobeNewswire Inc.

Alterity Therapeutics to Present New Data on ATH434 at the World Orphan Drug Congress USA 2024
Quarta, 10 de Abril de 2024 (1 semana atrás) • GlobeNewswire Inc.

Alterity Therapeutics Receives a A$3.9 Million Research & Development Tax Incentive Refund
Terça, 26 de Março de 2024 (4 semanas atrás) • GlobeNewswire Inc.

Alterity Therapeutics to Present New Data at the Upcoming American Academy of Neurology 2024 Annual Meeting
Terça, 20 de Fevereiro de 2024 (2 meses atrás) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Quinta, 15 de Fevereiro de 2024 (2 meses atrás) • Edgar (US Regulatory)

Form 424B5 - Prospectus [Rule 424(b)(5)]
Quinta, 15 de Fevereiro de 2024 (2 meses atrás) • Edgar (US Regulatory)

Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Second Review
Terça, 6 de Fevereiro de 2024 (2 meses atrás) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Quarta, 31 de Janeiro de 2024 (3 meses atrás) • Edgar (US Regulatory)

Alterity Therapeutics to Participate in the ShareCafe Hidden Gems Webinar This Week
Segunda, 29 de Janeiro de 2024 (3 meses atrás) • GlobeNewswire Inc.

Alterity Therapeutics Issues Shareholder Letter Highlighting Pipeline Advances and Key Upcoming Milestones
Segunda, 22 de Janeiro de 2024 (3 meses atrás) • GlobeNewswire Inc.

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Segunda, 22 de Janeiro de 2024 (3 meses atrás) • Edgar (US Regulatory)

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
Quinta, 18 de Janeiro de 2024 (3 meses atrás) • Edgar (US Regulatory)

Mais Notícias de Alterity Therapeutics Limited

Índice Bovespa

Delayed Upgrade Clock

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições